NQF endorses pulmonary and infectious disease measures

Luke Gale | | Health Exec | Economics

The National Quality Forum (NQF) has endorsed 14 infectious disease quality measures and an additional pulmonary quality measure.

The endorsements were made as NQF engages in an quality measure maintenance program to ensure that they are current, best-in-class and synchronistic with with national priorities, according to a Jan. 8 statement.

Visit the NQF website to view more details on the pulmonary and infectious disease quality measures. 

Luke Gale

Related Content

$3.3B merger of UnitedHealth and Amedisys delayed by DOJ lawsuit
Stryker acquires Inari Medical for $4.9B
Bill to regulate healthcare private equity lands on desk of Mass. governor
Mayo Clinic sues insurer over $740K in medical bills for patient
The biggest obstacles facing radiology business managers in 2025
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Around the web

Cardiovascular Business
Stryker acquires Inari Medical for $4.9B

Styker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Radiology Business
Policies and regulations shaping radiology in 2025

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year.